Avicanna Inc is Set to List on the TSX: CEO

    Avicanna Inc is a biopharmaceutical company that develops plant-derived cannabinoid-based products, says CEO Aras Azadian

    In this interview from the 2019 Benzinga Cannabis Capital Conference in Toronto, SmallCapPower spoke with Aras Azadian, CEO of Avicanna Inc, a biopharmaceutical company that develops and manufacturers plant-derived cannabinoid-based products. Mr. Azadian discusses the Company’s Colombia advantage, its commercialization efforts, as well as Avicanna’s scientific and clinical leadership.

    Hear directly from Investor Relations at Avicanna Inc.
    Sign up for our FREE daily investment newsletter

    We will never share your data with a third-party without your consent.

    Ubika Research/SmallCapPower has received compensation from Avicanna to provide analyst research coverage. For full disclosure please visit here >>

    To read our full disclosure, please click on the button below: